Philippines Pharmaceuticals & Healthcare Report Q1 2013: New Research Report Available at Fast Market Research
BMI View: BMI has revised up its forecast for the Philippines' pharmaceutical market following reassessment of the country's macroeconomic conditions. According to BMI's Country Risk team, the Philippine economy expanded by an impressive 5.9% year-on-year in Q212 due to strong growth from various sectors, such as services and exports. Consequently, we have upgraded the pharmaceutical market forecast. We continue to hold our view that pharmaceutical firms will see short-term opportunities in the Philippines due to ineffective governance of the prices...
View full press release